Treat to Target in Rheumatic Diseases: Rationale and Results
Treat to Target in Rheumatic Diseases: Rationale and Results
Guest edited by Dr. Daniel Aletaha, this issue of Rheumatic Disease Clinics will cover "Treat to Target in Rheumatic Diseases" with a focus on rationale and results. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman. Articles explore diseases, including, but not limited to: History, Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthropathies, Systemic lupus erythematosus, PMR and GCA, Inflammatory Myopathies (PM/DM), Gout, and Subclinical Targets.
PRP: 659.53 Lei
Acesta este Prețul Recomandat de Producător. Prețul de vânzare al produsului este afișat mai jos.
593.58Lei
593.58Lei
659.53 LeiPrimești 593 puncte
Indisponibil
Descrierea produsului
Guest edited by Dr. Daniel Aletaha, this issue of Rheumatic Disease Clinics will cover "Treat to Target in Rheumatic Diseases" with a focus on rationale and results. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman. Articles explore diseases, including, but not limited to: History, Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthropathies, Systemic lupus erythematosus, PMR and GCA, Inflammatory Myopathies (PM/DM), Gout, and Subclinical Targets.
Detaliile produsului
